9MEX | pdb_00009mex

Structure of phosphocysteine intermediate of human PRL1 phosphatase

External Resource: Annotation

Domain Annotation: SCOP2 Classification
Protein Family Annotation
Gene Ontology: Gene Product Annotation
InterPro: Protein Family Classification
Pharos: Disease Associations
Protein Modification Annotation

Domain Annotation: SCOP2 Classification SCOP2 Database Homepage

Chains	Type	Family Name	Domain Identifier	Family Identifier	Provenance Source (Version)
B	SCOP2B Superfamily	(Phosphotyrosine protein) phosphatases II	8042325	3000304	SCOP2B (2022-06-29)
A	SCOP2B Superfamily	(Phosphotyrosine protein) phosphatases II	8042325	3000304	SCOP2B (2022-06-29)

Protein Family Annotation Pfam Database Homepage

Chains	Accession	Name	Description	Comments	Source
A, B	PF22785	Polymorphic toxin system, DSP-PTPase phosphatase (Tc-R-P)	Polymorphic toxin system, DSP-PTPase phosphatase	This domain occupies the toxin tip position in a subset of polymorphic toxin domains [1,2]. This domain is found at the extreme C-terminal of certain polymorphic toxin-related Tc-like toxins deployed by bacteria against eukaryotic host cells. This po ...	This domain occupies the toxin tip position in a subset of polymorphic toxin domains [1,2]. This domain is found at the extreme C-terminal of certain polymorphic toxin-related Tc-like toxins deployed by bacteria against eukaryotic host cells. This position is where the toxin module delivered into the target cells host resides [1].	Domain

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A, B	Protein tyrosine phosphatase type IVA 1	phosphoric ester hydrolase activity phosphoprotein phosphatase activity catalytic activity, acting on a protein hydrolase activity, acting on ester bonds protein tyrosine phosphatase activity phosphatase activity hydrolase activity catalytic activity	positive regulation of locomotion regulation of biological process regulation of cell motility regulation of cellular process biological regulation positive regulation of biological process positive regulation of cell migration regulation of locomotion positive regulation of cell motility regulation of cell migration cellular process cell migration cell motility locomotion positive regulation of locomotion regulation of biological process regulation of cell motility regulation of cellular process biological regulation positive regulation of biological process positive regulation of cell migration regulation of locomotion positive regulation of cell motility regulation of cell migration cellular process cell migration cell motility locomotion positive regulation of cellular process	membrane-bounded organelle intracellular anatomical structure early endosome endosome intracellular vesicle intracellular membrane-bounded organelle endomembrane system intracellular organelle cellular anatomical structure cytoplasmic vesicle organelle cytoplasm vesicle cytoskeleton membrane-bounded organelle intracellular anatomical structure early endosome endosome intracellular vesicle intracellular membrane-bounded organelle endomembrane system intracellular organelle cellular anatomical structure cytoplasmic vesicle organelle cytoplasm vesicle cytoskeleton spindle membraneless organelle intracellular membraneless organelle microtubule cytoskeleton cell periphery cytoplasmic side of plasma membrane cytoplasmic side of membrane membrane plasma membrane side of membrane nucleus endoplasmic reticulum

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A, B	IPR050561	Protein Tyrosine Phosphatase	Family
A, B	IPR029021	Protein-tyrosine phosphatase-like	Homologous Superfamily
A, B	IPR003595	Protein-tyrosine phosphatase, catalytic	Domain
A, B	IPR000387	Tyrosine-specific protein phosphatases domain	Domain
A, B	IPR020422	Dual specificity protein phosphatase domain	Domain

Pharos: Disease Associations Pharos Homepage Annotation

Chains	Drug Target	Associated Disease
A, B	Pharos: Q93096	lung cancer medulloblastoma pancreatic ductal adenocarcinoma Pneumocystis Carinii Pneumonia Prevention psoriasis breast cancer transitional cell carcinoma dermatomyositis gastric cancer hereditary spastic paraplegia interstitial lung disease limb-girdle muscular dystrophy malignant colon neoplasm osteosarcoma Pick disease lung cancer medulloblastoma pancreatic ductal adenocarcinoma Pneumocystis Carinii Pneumonia Prevention psoriasis breast cancer transitional cell carcinoma dermatomyositis gastric cancer hereditary spastic paraplegia interstitial lung disease limb-girdle muscular dystrophy malignant colon neoplasm osteosarcoma Pick disease pneumocystosis Alzheimer disease Sjogren syndrome breast carcinoma Duchenne muscular dystrophy gastric carcinoma human African trypanosomiasis invasive ductal breast carcinoma lung adenocarcinoma malignant pancreatic neoplasm ovarian cancer plasma cell myeloma progressive supranuclear palsy astrocytic tumor Tourette syndrome cutaneous lupus erythematosus exocrine pancreatic carcinoma hepatocellular carcinoma IgA glomerulonephritis juvenile dermatomyositis

Protein Modification Annotation

Modified Residue(s)
Chain	Residue(s)	Description
A, B	CSP	Parent Component: CYS RESID: AA0034 PSI-MOD : S-phospho-L-cysteine MOD:00043

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.